Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-28 8:27:40 pm | Atea Pharmaceuticals, Inc. (AVIR) Q4 2023 Earnings Call Transcript | SeekingAlpha |
| 2024-02-28 1:58:39 pm | Atea Pharmaceuticals Inc (AVIR) Announces Q4 and Full Year 2023 Financial Results | GuruFocus.com |
| 2024-02-28 1:5:0 pm | Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | GlobeNewswire |
| 2024-02-21 4:0:0 am | Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024 | GlobeNewswire |
| 2024-01-10 6:30:0 am | Atea Pharma (AVIR) Gains on Upbeat Initial Data From HCV Study | Zacks |
| 2024-01-08 1:5:0 pm | Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19 | GlobeNewswire |
| 2024-01-03 4:0:0 am | Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information